934 results on '"Ishii, Ken J"'
Search Results
52. Supplementary Figure 6 from RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma
53. Supplementary Figure 3 from RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma
54. Supplementary Figure 5 from RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma
55. Data from RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma
56. Supplementary Figure 2 from RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma
57. Supplementary Figure 4 from RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma
58. Supplementary Figure 7 from RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma
59. Supplementary Figure 1 from RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma
60. Spermidine enhances the efficacy of adjuvant in HBV vaccination in mice
61. A-910823, a squalene-based emulsion adjuvant, induces T follicular helper cells and humoral immune responses via α-tocopherol component
62. Exploring the relationship between anti-PEG IgM behaviors and PEGylated nanoparticles and its significance for accelerated blood clearance
63. Intranasal hydroxypropyl-β-cyclodextrin-adjuvanted influenza vaccine protects against sub-heterologous virus infection
64. Current status of synthetic hemozoin adjuvant: A preliminary safety evaluation
65. Optimization of physiological properties of hydroxyapatite as a vaccine adjuvant
66. Particulate and Immunity
67. Immunization with antigenic peptides complexed with β-glucan induces potent cytotoxic T-lymphocyte activity in combination with CpG-ODNs
68. Eosinophil depletion suppresses radiation-induced small intestinal fibrosis
69. Exposure of an occluded hemagglutinin epitope drives selection of a class of cross-protective influenza antibodies
70. STING agonists activate latently infected cells and enhance SIV-specific responses ex vivo in naturally SIV controlled cynomolgus macaques
71. Anti-Inflammatory Role of TRPV4 in Human Macrophages
72. RNA Polymerase III Regulates Cytosolic RNA:DNA Hybrids and Intracellular MicroRNA Expression
73. Oncolytic adenovirus serotype 35 mediated tumor growth suppressionviaefficient activation and tumor infiltration of natural killer cells
74. Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5
75. Proposal for the revision of guidelines for clinical trials of vaccines to prevent infectious diseases in Japan
76. Immune Recognition of Nucleic Acids and Their Metabolites
77. Protective properties of a fusion pneumococcal surface protein A (PspA) vaccine against pneumococcal challenge by five different PspA clades in mice
78. Hemozoin as a novel adjuvant for inactivated whole virion influenza vaccine
79. Hemozoin is a potent adjuvant for hemagglutinin split vaccine without pyrogenicity in ferrets
80. Immune Interventions of Human Diseases through Toll-Like Receptors
81. Induction of humoural and cellular immunity by immunisation with HCV particle vaccine in a non-human primate model
82. Nonagonistic Dectin-1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonist
83. Identification of RPL15 60S Ribosomal Protein as a Novel Topotecan Target Protein That Correlates with DAMP Secretion and Antitumor Immune Activation
84. Nucleic Acid-based Immuno-prophylaxis and -therapies against Tropical Diseases
85. Safety and immunogenicity of a quadrivalent seasonal influenza vaccine adjuvanted with hydroxypropyl-β-cyclodextrin: A phase 1 clinical trial
86. Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike
87. Machine Learning-Assisted Screening of Herbal Medicine Extracts as Vaccine Adjuvants
88. Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon
89. Immunoprotective Activity of CpG Oligonucleotides
90. DNA damage sensor MRE11 recognizes cytosolic double-stranded DNA and induces type I interferon by regulating STING trafficking
91. Activation of the innate immune system by CpG oligodeoxynucleotides: immunoprotective activity and safety
92. Efficacy comparison of adjuvants in PcrV vaccine against Pseudomonas aeruginosa pneumonia
93. Spermidine enhances the efficacy of adjuvant in HBV vaccination in mice.
94. Contribution of IL-33–activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice
95. Anti-tumor immunity by transcriptional synergy between TLR9 and STING activation
96. Proposal for the revision of the guidelines for Non-clinical studies of vaccines for the prevention of infectious diseases in Japan
97. CpG ODN (K3)—Toll-Like Receptor 9 Agonist—Induces Th1-type Immune Response and Enhances Cytotoxic Activity in Advanced Lung Cancer Patients: A Phase I Study
98. Particulate-Driven Type-2 Immunity and Allergic Responses
99. Additional file 2 of CpG ODN (K3)—toll-like receptor 9 agonist—induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I study
100. Additional file 1 of CpG ODN (K3)—toll-like receptor 9 agonist—induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.